AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sandvik

Prospectus Apr 28, 2014

2960_prs_2014-04-28_da4d241a-c1b9-4433-95db-f9275f2007be.pdf

Prospectus

Open in Viewer

Opens in native device viewer

SUPPLEMENT DATED 28 April 2014 TO THE BASE PROSPECTUS DATED 17 July 2013

SANDVIK AB (PUBL)

(incorporated with limited liability in the Kingdom of Sweden) as an Issuer and as Guarantor

SANDVIK AUSTRALIA HOLDINGS PTY LTD

ABN 60 003 771 373

(incorporated with limited liability in Australia) as an Issuer

€3,000,000,000 Euro Medium Term Note Programme

This Supplement (the "Supplement") to the base prospectus dated 17 July 2013 (the "Base Prospectus") which together comprise a prospectus for the purposes of Article 5.4 of Directive 2003/71/EC (the "Prospectus Directive"), constitutes a supplementary prospectus for the purposes of Section 87G of the Financial Services and Markets Act 2000 (the "FSMA") and is prepared in connection with the €3,000,000,000 Euro Medium Term Programme (the "Programme") established by Sandvik AB (publ) ("Sandvik") and Sandvik Australia Holdings Pty Ltd ("Sandvik Australia", each an "Issuer" and together, the "Issuers"). Terms defined in the Base Prospectus have the same meaning when used in this Supplement.

This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus and any other supplements to the Base Prospectus issued by the Issuers.

Each of the Issuers, and Sandvik as Guarantor (the "Guarantor", together with the Issuers, the "Obligors" and each, and "Obligor") accepts responsibility for the information contained in this Supplement and declares that, having taken all reasonable care to ensure that such is the case, the information contained in this Supplement is, to the best of its knowledge, in accordance with the facts and contains no omission likely to affect its import.

The purpose of this Supplement is to incorporate by reference the unaudited consolidated financial statements of Sandvik as of and for the three months ended 31 March 2014 (the "Q1 2014 Sandvik Financial Statements") into the Base Prospectus.

Publication of Sandvik's first quarter results

On 25 April 2014, Sandvik published its Q1 2014 Sandvik Financial Statements which can be found on pages 12 to 17 of Sandvik's interim report dated 25 April 2014. A copy of the interim report dated 25 April 2014 has been filed with the Financial Conduct Authority and, by virtue of this Supplement, those unaudited consolidated financial statements are incorporated in, and form part of, the Base Prospectus.

Copies of all documents incorporated by reference in the Base Prospectus may be inspected, free of charge, at www.sandvik.com or www.morningstar.co.uk/uk/NSM.

There has been no significant change in the financial or trading position of Sandvik or Sandvik and its subsidiaries taken as a whole, in each case since 31 March 2014.

If documents which are incorporated by reference into this Supplement to the Base Prospectus themselves incorporate any information or other documents therein, either expressly or implicitly, such information or other documents will not form part of this Supplement for the purposes of the Prospectus Directive except where such information or other documents are specifically incorporated by reference or attached to this Supplement.

Any information contained in any of the documents specified above which is not incorporated by reference in the Base Prospectus is either not relevant to investors or is covered elsewhere in the Base Prospectus. Any documents themselves incorporated by reference in the documents incorporated by reference in the Base Prospectus shall not form part of the Base Prospectus.

To the extent that there is any inconsistency between (a) any statement in this Supplement or any statement incorporated by reference into the Base Prospectus by this Supplement and (b) any other statement in or incorporated by reference in the Base Prospectus prior to the date of this Supplement, the statements in (a) will prevail.

Investors should be aware of their rights under Section 87Q(4)-(6) of FSMA.

This Supplement has been approved by the FCA which is the United Kingdom competent authority for the Prospectus Directive and the relevant implementing measures in the United Kingdom, as a supplementary prospectus issued in compliance with the Prospectus Directive and relevant implementing measures in the United Kingdom.

No person is or has been authorised by the Issuers to give any information or to make any representation not contained in or not consistent with the Base Prospectus or this Supplement or any other information supplied in connection with the Programme or the Notes and, if given or made, such information or representation must not be relied upon as having been authorised by the Obligors or any of the Dealers.

Neither the delivery of the Base Prospectus and/or this Supplement nor the offering, sale or delivery of any Notes shall in any circumstances imply that the information contained herein concerning the Obligors is correct at any time subsequent to the date hereof or that any other information supplied in connection with the Programme is correct as of any time subsequent to the date indicated in the document containing the same.

Talk to a Data Expert

Have a question? We'll get back to you promptly.